KLTO: חוב לטווח קצר של החברה Klotho Neurosciences Inc

High barriers to entry in neurobiology and patent protection for longevity proteins limit competition in the Klotho Neurosciences Inc (KLTO) niche. Short-term loan capital on GURU.Markets reflects borrowing dynamics, where this metric equals 0.00. Klotho Neurosciences Inc (KLTO) is accelerating the development of s-Klotho therapy against Alzheimer's and ALS, utilizing AI platforms for protein modeling to fully automate routine laboratory processes.

Investors assess business resilience through the ability to cover obligations with a maturity horizon of up to one year to eliminate default risk. The amount of current borrowings, reflecting the costs incurred by Klotho Neurosciences Inc. (KLTO) to maintain an expensive cold chain during drug delivery, determines the company's liquidity, allowing for the monitoring of short-term borrowing levels to identify potential cash flow gaps.